<!DOCTYPE html>
<html lang="en-GB">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Methylene Blue for Vasoplegia - UHBW ICU Guidelines</title>
    <style>
        :root {
            --nhs-blue: #005EB8;
            --nhs-dark-blue: #003087;
            --nhs-light-blue: #41B6E6;
            --nhs-red: #DA291C;
            --nhs-orange: #ED8B00;
            --nhs-yellow: #FFE000;
            --nhs-green: #007F3B;
            --nhs-grey: #768692;
            --nhs-dark-grey: #425563;
        }
        
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }
        
        body {
            font-family: -apple-system, BlinkMacSystemFont, 'Frutiger', Arial, sans-serif;
            line-height: 1.5;
            color: #212b32;
            background: #f0f4f5;
            font-size: 15px;
        }
        
        .header {
            background: linear-gradient(135deg, var(--nhs-dark-blue) 0%, var(--nhs-blue) 100%);
            color: white;
            padding: 2rem 1.5rem;
            box-shadow: 0 2px 6px rgba(0,0,0,0.15);
        }
        
        .header h1 {
            font-size: 2rem;
            font-weight: 600;
            margin-bottom: 0.5rem;
        }
        
        .header-subtitle {
            font-size: 1.1rem;
            opacity: 0.95;
            margin-bottom: 1rem;
        }
        
        .header-meta {
            display: flex;
            gap: 1.5rem;
            flex-wrap: wrap;
            font-size: 0.9rem;
            margin-top: 1rem;
        }
        
        .meta-item {
            background: rgba(255, 255, 255, 0.1);
            padding: 0.4rem 0.8rem;
            border-radius: 4px;
        }
        
        .container {
            max-width: 1400px;
            margin: 0 auto;
            padding: 1.5rem;
        }
        
        .alert-box {
            background: linear-gradient(135deg, #fff4e5 0%, #fff8f0 100%);
            border-left: 4px solid var(--nhs-orange);
            padding: 1.2rem;
            margin: 1.5rem 0;
            box-shadow: 0 2px 4px rgba(0,0,0,0.1);
            border-radius: 0 4px 4px 0;
        }
        
        .alert-box.critical {
            background: linear-gradient(135deg, #ffe5e5 0%, #fff0f0 100%);
            border-left-color: var(--nhs-red);
        }
        
        .alert-box strong {
            color: var(--nhs-orange);
            font-size: 1.1rem;
            display: block;
            margin-bottom: 0.5rem;
        }
        
        .alert-box.critical strong {
            color: var(--nhs-red);
        }
        
        .tabs {
            display: flex;
            gap: 0.5rem;
            margin: 1.5rem 0 0 0;
            flex-wrap: wrap;
            border-bottom: 2px solid var(--nhs-blue);
        }
        
        .tab {
            background: white;
            border: none;
            padding: 0.8rem 1.2rem;
            cursor: pointer;
            font-size: 0.95rem;
            font-weight: 600;
            color: var(--nhs-dark-grey);
            border-radius: 6px 6px 0 0;
            transition: all 0.3s;
            border: 2px solid transparent;
            border-bottom: none;
            position: relative;
            bottom: -2px;
        }
        
        .tab:hover {
            background: var(--nhs-light-blue);
            color: white;
        }
        
        .tab.active {
            background: var(--nhs-blue);
            color: white;
            border-color: var(--nhs-blue);
        }
        
        .tab-content {
            display: none;
            background: white;
            padding: 2rem;
            border-radius: 0 4px 4px 4px;
            box-shadow: 0 2px 8px rgba(0,0,0,0.1);
        }
        
        .tab-content.active {
            display: block;
        }
        
        h2 {
            font-size: 1.5rem;
            margin-bottom: 1.2rem;
            color: var(--nhs-dark-blue);
            border-bottom: 2px solid var(--nhs-blue);
            padding-bottom: 0.5rem;
        }
        
        h3 {
            font-size: 1.2rem;
            margin: 1.5rem 0 0.8rem 0;
            color: var(--nhs-dark-blue);
        }
        
        h4 {
            font-size: 1.05rem;
            margin: 1rem 0 0.5rem 0;
            color: var(--nhs-dark-grey);
        }
        
        .info-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
            gap: 1rem;
            margin: 1.5rem 0;
        }
        
        .info-card {
            background: #f8f9fa;
            border-left: 4px solid var(--nhs-blue);
            padding: 1.2rem;
            border-radius: 0 4px 4px 0;
        }
        
        .info-card h4 {
            color: var(--nhs-blue);
            margin: 0 0 0.8rem 0;
        }
        
        .indications-box {
            background: #e8f4f8;
            border: 2px solid var(--nhs-blue);
            border-radius: 6px;
            padding: 1.5rem;
            margin: 1.5rem 0;
        }
        
        .indications-box h3 {
            color: var(--nhs-blue);
            margin-top: 0;
        }
        
        .criteria-list {
            background: white;
            padding: 1rem;
            border-radius: 4px;
            margin: 1rem 0;
        }
        
        .criteria-list li {
            margin: 0.8rem 0;
            padding-left: 0.5rem;
        }
        
        .dosing-section {
            background: linear-gradient(135deg, #f0f8ff 0%, #e8f4f8 100%);
            border: 2px solid var(--nhs-blue);
            border-radius: 8px;
            padding: 1.5rem;
            margin: 1.5rem 0;
        }
        
        .dosing-table {
            width: 100%;
            border-collapse: collapse;
            margin: 1rem 0;
            background: white;
            box-shadow: 0 2px 4px rgba(0,0,0,0.1);
        }
        
        .dosing-table th {
            background: var(--nhs-blue);
            color: white;
            padding: 1rem;
            text-align: left;
            font-weight: 600;
        }
        
        .dosing-table td {
            padding: 1rem;
            border-bottom: 1px solid #e0e0e0;
        }
        
        .dosing-table tr:last-child td {
            border-bottom: none;
        }
        
        .calculator-section {
            background: white;
            border: 2px solid var(--nhs-green);
            border-radius: 8px;
            padding: 1.5rem;
            margin: 1.5rem 0;
        }
        
        .calculator-section h3 {
            color: var(--nhs-green);
            margin-top: 0;
        }
        
        .input-group {
            margin: 1rem 0;
        }
        
        .input-group label {
            display: block;
            font-weight: 600;
            margin-bottom: 0.5rem;
            color: var(--nhs-dark-grey);
        }
        
        .input-group input,
        .input-group select {
            width: 100%;
            padding: 0.8rem;
            border: 2px solid #e0e0e0;
            border-radius: 4px;
            font-size: 1rem;
        }
        
        .input-group input:focus,
        .input-group select:focus {
            outline: none;
            border-color: var(--nhs-blue);
        }
        
        .calc-button {
            background: var(--nhs-green);
            color: white;
            border: none;
            padding: 1rem 2rem;
            font-size: 1rem;
            font-weight: 600;
            border-radius: 4px;
            cursor: pointer;
            transition: all 0.3s;
            margin-top: 1rem;
        }
        
        .calc-button:hover {
            background: #006030;
            transform: translateY(-1px);
            box-shadow: 0 4px 8px rgba(0,0,0,0.15);
        }
        
        .results-box {
            display: none;
            background: #f0f8ff;
            border: 2px solid var(--nhs-blue);
            border-radius: 6px;
            padding: 1.5rem;
            margin-top: 1.5rem;
        }
        
        .results-box.show {
            display: block;
        }
        
        .result-item {
            background: white;
            padding: 1rem;
            margin: 0.8rem 0;
            border-radius: 4px;
            border-left: 4px solid var(--nhs-blue);
        }
        
        .result-value {
            font-size: 1.3rem;
            font-weight: 700;
            color: var(--nhs-blue);
            margin: 0.3rem 0;
        }
        
        .adverse-effects-table {
            width: 100%;
            border-collapse: collapse;
            margin: 1rem 0;
            background: white;
            box-shadow: 0 2px 4px rgba(0,0,0,0.1);
        }
        
        .adverse-effects-table th {
            background: var(--nhs-orange);
            color: white;
            padding: 0.8rem;
            text-align: left;
            font-weight: 600;
        }
        
        .adverse-effects-table td {
            padding: 0.8rem;
            border-bottom: 1px solid #e0e0e0;
            vertical-align: top;
        }
        
        .adverse-effects-table tr:last-child td {
            border-bottom: none;
        }
        
        .monitoring-item {
            background: #fff4e5;
            padding: 0.8rem;
            margin: 0.5rem 0;
            border-left: 3px solid var(--nhs-orange);
            border-radius: 0 4px 4px 0;
        }
        
        .references {
            background: #f8f9fa;
            padding: 1.5rem;
            border-radius: 6px;
            margin: 2rem 0;
        }
        
        .references h3 {
            color: var(--nhs-dark-blue);
            margin-top: 0;
        }
        
        .references ol {
            padding-left: 1.5rem;
        }
        
        .references li {
            margin: 0.8rem 0;
            line-height: 1.6;
        }
        
        .key-point {
            background: linear-gradient(135deg, #e8f4f8 0%, #f0f8ff 100%);
            border-left: 4px solid var(--nhs-blue);
            padding: 1rem;
            margin: 1rem 0;
            border-radius: 0 4px 4px 0;
        }
        
        .key-point strong {
            color: var(--nhs-blue);
        }
        
        @media (max-width: 768px) {
            .header h1 {
                font-size: 1.5rem;
            }
            
            .container {
                padding: 1rem;
            }
            
            .tab-content {
                padding: 1.2rem;
            }
            
            .tabs {
                gap: 0.3rem;
            }
            
            .tab {
                padding: 0.6rem 0.8rem;
                font-size: 0.85rem;
            }
            
            .dosing-table,
            .adverse-effects-table {
                font-size: 0.9rem;
            }
            
            .dosing-table th,
            .dosing-table td,
            .adverse-effects-table th,
            .adverse-effects-table td {
                padding: 0.6rem;
            }
        }
    </style>
</head>
<body>
    <div class="header">
        <h1>Methylene Blue (Methylthioninium Chloride) for Vasoplegia</h1>
        <div class="header-subtitle">Critical Care Clinical Guideline - UNLICENSED & NON-FORMULARY</div>
        <div class="header-meta">
            <div class="meta-item">Version 1.00</div>
            <div class="meta-item">Author: Matt Govier (ICU Consultant)</div>
            <div class="meta-item">Valid: May 2023 - May 2027</div>
            <div class="meta-item">Setting: A600, C604, Weston ICU</div>
        </div>
    </div>

    <div class="container">
        <div class="alert-box critical">
            <strong>⚠️ CONSULTANT-INITIATED THERAPY ONLY</strong>
            Methylene blue is unlicensed for vasoplegia and non-formulary. This therapy should only be initiated following consultant approval. Non-formulary paperwork is required but should not delay treatment. Contact ICU Pharmacist for assistance.
        </div>

        <div class="info-grid">
            <div class="info-card">
                <h4>Setting</h4>
                <p>Adult ICU units at UHBW: General ICU (A600), Cardiac ICU (C604), and Weston ICU</p>
            </div>
            <div class="info-card">
                <h4>For Staff</h4>
                <p>ICU nurses, advanced critical care practitioners, and medical staff</p>
            </div>
            <div class="info-card">
                <h4>Patient Group</h4>
                <p>Patients with severe vasoplegic shock (post-CPB, sepsis, toxicology) refractory to standard vasopressor therapy</p>
            </div>
        </div>

        <div class="tabs">
            <button class="tab active" onclick="showTab('indication')">Indication & Mechanism</button>
            <button class="tab" onclick="showTab('dosing')">Dosing & Administration</button>
            <button class="tab" onclick="showTab('calculator')">Dose Calculator</button>
            <button class="tab" onclick="showTab('monitoring')">Monitoring & Adverse Effects</button>
            <button class="tab" onclick="showTab('safety')">Safety & Interactions</button>
            <button class="tab" onclick="showTab('references')">References</button>
        </div>

        <div id="indication" class="tab-content active">
            <h2>Indication & Mechanism of Action</h2>
            
            <div class="key-point">
                <strong>Mechanism:</strong> Methylene blue competitively inhibits nitric oxide by binding to the iron haem-moiety of soluble guanylate cyclase enzyme. This blocks cGMP-mediated calcium extrusion from vascular smooth muscle, counteracting vasodilation and reversing vasoplegia.
            </div>

            <h3>Clinical Context</h3>
            <p>Patients with severe vasoplegic shock present significant treatment challenges. Excessive catecholamine doses cause serious adverse effects including arrhythmias, myocardial ischaemia, and increased mortality. Methylene blue acts on non-catecholamine pathways, potentially reducing vasopressor requirements and limiting catecholamine-related complications.</p>

            <div class="indications-box">
                <h3>When to Consider Methylene Blue</h3>
                <p><strong>All of the following criteria must be met:</strong></p>
                
                <div class="criteria-list">
                    <ul>
                        <li><strong>Adequate fluid resuscitation</strong> - Patient must be appropriately volume loaded</li>
                        <li><strong>High-dose noradrenaline</strong> - Dose >0.5 mcg/kg/min</li>
                        <li><strong>Vasopressin therapy</strong> - Dose >0.02 units/min</li>
                        <li><strong>Vasopressor-dose corticosteroids</strong> - Hydrocortisone 50mg QDS IV</li>
                        <li><strong>Optimised cardiac output</strong> - Inodilator agents reduced whilst maintaining adequate cardiac output</li>
                        <li><strong>Confirmed vasoplegic state</strong> - Documented by cardiac output monitoring or echocardiography</li>
                        <li><strong>Progressive deterioration</strong> - Despite maximal conventional therapy</li>
                    </ul>
                </div>
            </div>

            <div class="alert-box">
                <strong>Essential Prerequisite</strong>
                Cardiac output monitoring or echocardiographic assessment must confirm a vasoplegic state (low SVR with preserved or elevated cardiac output) prior to administration.
            </div>

            <h3>Common Aetiologies of Vasoplegia</h3>
            <ul style="padding-left: 2rem; margin: 1rem 0;">
                <li>Post-cardiopulmonary bypass (CPB) - particularly prolonged bypass times</li>
                <li>Septic shock - especially gram-negative sepsis</li>
                <li>Toxicology - calcium channel blocker overdose, beta-blocker toxicity</li>
                <li>Anaphylaxis</li>
                <li>Post-cardiac arrest</li>
            </ul>
        </div>

        <div id="dosing" class="tab-content">
            <h2>Prescribing & Administration</h2>

            <div class="alert-box critical">
                <strong>⚠️ CRITICAL COMPATIBILITY INFORMATION</strong>
                Methylene blue is INCOMPATIBLE with sodium chloride 0.9%. All dilutions and line flushing MUST use glucose 5% only. Failure to follow this can result in precipitation and line occlusion.
            </div>

            <div class="alert-box">
                <strong>Important Dosing Considerations</strong>
                <ul style="margin-top: 0.5rem; padding-left: 1.5rem;">
                    <li>All doses calculated using <strong>LEAN body weight</strong></li>
                    <li><strong>Central venous administration</strong> recommended</li>
                    <li>Peripheral administration only in emergencies - maximum concentration 1mg/ml</li>
                    <li>Available as 5mg/ml and 10mg/ml preparations - exercise caution</li>
                </ul>
            </div>

            <div class="dosing-section">
                <h3>Initial Bolus Dose</h3>
                <div class="key-point">
                    <strong>Dose:</strong> 1-2 mg/kg (lean body weight)<br>
                    <strong>Preparation:</strong> Dilute to 50ml total volume with glucose 5%<br>
                    <strong>Administration:</strong> Infuse over 15-60 minutes via central line
                </div>

                <h4 style="margin-top: 1.5rem;">Renal Impairment Adjustment</h4>
                <p>Consider reducing initial bolus to <strong>&lt;1mg/kg</strong> in patients with renal impairment</p>
            </div>

            <div class="dosing-section">
                <h3>Ongoing Therapy (if positive response to initial bolus)</h3>
                <p style="margin-bottom: 1rem;">Choose either repeated boluses OR continuous infusion:</p>

                <table class="dosing-table">
                    <thead>
                        <tr>
                            <th>Method</th>
                            <th>Preparation</th>
                            <th>Dosing</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>Repeated Boluses</strong></td>
                            <td>
                                1-2 mg/kg in glucose 5%<br>
                                Total volume: 50ml
                            </td>
                            <td>
                                Infuse over 15-60 minutes<br>
                                Repeat every <strong>2-3 hours</strong> as required
                            </td>
                        </tr>
                        <tr>
                            <td><strong>Continuous Infusion</strong></td>
                            <td>
                                500mg methylene blue in glucose 5%<br>
                                Total volume: 250ml<br>
                                Final concentration: <strong>2mg/ml</strong>
                            </td>
                            <td>
                                Rate: <strong>0.25 - 2 mg/kg/hr</strong><br>
                                (0.125 - 1 ml/kg/hr)<br>
                                Start 2 hours after initial bolus
                            </td>
                        </tr>
                    </tbody>
                </table>

                <div class="alert-box" style="margin-top: 1rem;">
                    <strong>Renal Impairment:</strong> Use lower end of infusion range (0.25 mg/kg/hr) in patients with renal dysfunction
                </div>
            </div>

            <h3>Special Populations</h3>
            <div class="info-card">
                <h4>Hepatic Impairment</h4>
                <p>No experience in patients with severe hepatic impairment. Use with extreme caution and consider dose reduction.</p>
            </div>
        </div>

        <div id="calculator" class="tab-content">
            <h2>Methylene Blue Dose Calculator</h2>

            <div class="calculator-section">
                <h3>Patient Parameters</h3>
                
                <div class="input-group">
                    <label for="leanWeight">Lean Body Weight (kg)</label>
                    <input type="number" id="leanWeight" placeholder="Enter lean body weight" min="30" max="150" step="0.1">
                </div>

                <div class="input-group">
                    <label for="renalFunction">Renal Function</label>
                    <select id="renalFunction">
                        <option value="normal">Normal renal function</option>
                        <option value="impaired">Renal impairment</option>
                    </select>
                </div>

                <div class="input-group">
                    <label for="bolusDose">Bolus Dose (mg/kg)</label>
                    <select id="bolusDose">
                        <option value="1">1 mg/kg (conservative)</option>
                        <option value="1.5">1.5 mg/kg</option>
                        <option value="2">2 mg/kg (standard)</option>
                    </select>
                </div>

                <div class="input-group">
                    <label for="preparation">Available Preparation</label>
                    <select id="preparation">
                        <option value="5">5 mg/ml</option>
                        <option value="10">10 mg/ml</option>
                    </select>
                </div>

                <button class="calc-button" onclick="calculateDose()">Calculate Doses</button>

                <div id="results" class="results-box">
                    <h3 style="color: var(--nhs-blue); margin-bottom: 1rem;">Calculated Doses</h3>
                    
                    <div class="result-item">
                        <strong>Initial Bolus Dose</strong>
                        <div class="result-value" id="bolusTotal"></div>
                        <div id="bolusPrep"></div>
                        <div style="margin-top: 0.5rem; font-size: 0.9rem; color: var(--nhs-grey);">
                            Dilute to 50ml total volume with glucose 5%. Infuse over 15-60 minutes.
                        </div>
                    </div>

                    <div class="result-item">
                        <strong>Repeated Bolus Regimen</strong>
                        <div class="result-value" id="repeatBolus"></div>
                        <div id="repeatPrep"></div>
                        <div style="margin-top: 0.5rem; font-size: 0.9rem; color: var(--nhs-grey);">
                            Repeat every 2-3 hours as required. Monitor response and adverse effects.
                        </div>
                    </div>

                    <div class="result-item">
                        <strong>Continuous Infusion Alternative</strong>
                        <div class="result-value" id="infusionRate"></div>
                        <div id="infusionDetails"></div>
                        <div style="margin-top: 0.5rem; font-size: 0.9rem; color: var(--nhs-grey);">
                            Prepare: 500mg in 250ml glucose 5% (2mg/ml). Start 2 hours after initial bolus.
                        </div>
                    </div>
                </div>
            </div>
        </div>

        <div id="monitoring" class="tab-content">
            <h2>Monitoring & Adverse Effects</h2>

            <div class="alert-box">
                <strong>Essential Monitoring Requirements</strong>
                <ul style="margin-top: 0.5rem; padding-left: 1.5rem;">
                    <li>Continuous SpO2 monitoring during and for 4 hours post-administration</li>
                    <li>CNS assessment for 4 hours after each dose</li>
                    <li>Methaemoglobin levels every 4 hours if using infusion or repeated boluses</li>
                    <li>Continuous cardiac monitoring</li>
                    <li>Blood pressure monitoring</li>
                    <li>Arterial blood gas analysis as required</li>
                </ul>
            </div>

            <h3>Adverse Effects and Management</h3>

            <table class="adverse-effects-table">
                <thead>
                    <tr>
                        <th style="width: 35%;">Adverse Effect</th>
                        <th>Monitoring & Management</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>CNS Toxicity</strong><br>
                        Dizziness, headache, tremors, mental confusion</td>
                        <td>
                            <strong>Monitoring:</strong> Neurological observations during and for 4 hours post-dose<br>
                            <strong>Management:</strong> Minimise dose, provide supportive care. If features of CNS toxicity develop, monitor closely and give supportive treatment.
                        </td>
                    </tr>
                    <tr>
                        <td><strong>Pulse Oximetry Interference</strong><br>
                        Falsely low SpO2 readings</td>
                        <td>
                            <strong>Monitoring:</strong> Continuous SpO2 during and for 4 hours post-administration<br>
                            <strong>Management:</strong> If SpO2 appears falsely low, check arterial PaO2 on blood gas. Provide supplemental oxygen as clinically indicated.
                        </td>
                    </tr>
                    <tr>
                        <td><strong>Cardiac Arrhythmias</strong></td>
                        <td>
                            <strong>Monitoring:</strong> Continuous ECG monitoring<br>
                            <strong>Management:</strong> Consider reducing methylene blue or other vasoactive agents. Treat arrhythmias with standard antiarrhythmic protocols.
                        </td>
                    </tr>
                    <tr>
                        <td><strong>Hypertension</strong></td>
                        <td>
                            <strong>Monitoring:</strong> Continuous arterial pressure monitoring<br>
                            <strong>Management:</strong> Assess fluid status. Consider reducing methylene blue or other vasopressor doses.
                        </td>
                    </tr>
                    <tr>
                        <td><strong>Hypotension</strong></td>
                        <td>
                            <strong>Monitoring:</strong> Continuous arterial pressure monitoring<br>
                            <strong>Management:</strong> Assess fluid status. Consider increasing other vasopressor agents.
                        </td>
                    </tr>
                    <tr>
                        <td><strong>Methaemoglobinaemia</strong></td>
                        <td>
                            <strong>Monitoring:</strong> Check MetHb levels on arterial blood gas every 4 hours during infusion/repeated boluses<br>
                            <strong>Management:</strong> If MetHb >5%, reduce or stop infusion and do not give further boluses.
                        </td>
                    </tr>
                    <tr>
                        <td><strong>Gastrointestinal</strong><br>
                        Nausea</td>
                        <td>
                            <strong>Management:</strong> Consider antiemetic therapy
                        </td>
                    </tr>
                    <tr>
                        <td><strong>Blue Discolouration</strong><br>
                        Urine, stools, saliva</td>
                        <td>
                            <strong>Management:</strong> Reassure patient and healthcare staff. This is expected and harmless.
                        </td>
                    </tr>
                </tbody>
            </table>

            <div class="monitoring-item">
                <strong>Positive Response Indicators:</strong> Reduction in vasopressor requirements, improved blood pressure, increased systemic vascular resistance
            </div>

            <div class="monitoring-item">
                <strong>Duration of Effect:</strong> If effective, expect response within 1-2 hours of initial bolus. Duration of action typically 2-4 hours, hence timing of repeat dosing.
            </div>
        </div>

        <div id="safety" class="tab-content">
            <h2>Safety Considerations & Drug Interactions</h2>

            <div class="alert-box critical">
                <strong>⚠️ MHRA SAFETY WARNING - Serotonergic Drug Interactions</strong>
                The MHRA has issued specific guidance on methylene blue use with serotonergic antidepressants due to risk of central nervous system toxicity.
            </div>

            <h3>Serotonergic Drug Interactions</h3>
            <div class="indications-box" style="background: #ffe5e5; border-color: var(--nhs-red);">
                <h4 style="color: var(--nhs-red); margin-top: 0;">High-Risk Interactions</h4>
                <p><strong>Intravenous methylthioninium chloride should be AVOIDED in patients recently treated with:</strong></p>
                <ul style="padding-left: 1.5rem; margin-top: 0.5rem;">
                    <li>Selective serotonin reuptake inhibitors (SSRIs)</li>
                    <li>Clomipramine</li>
                    <li>Venlafaxine</li>
                    <li>Other serotonergic antidepressants</li>
                </ul>

                <h4 style="color: var(--nhs-red); margin-top: 1rem;">If Use Cannot Be Avoided:</h4>
                <ul style="padding-left: 1.5rem; margin-top: 0.5rem;">
                    <li>Use the <strong>lowest possible dose</strong></li>
                    <li>Observe patient <strong>closely for CNS effects</strong> for up to 4 hours after administration</li>
                    <li>Watch for signs of serotonin syndrome: agitation, confusion, neuromuscular hyperactivity, autonomic instability</li>
                    <li>If CNS toxicity develops, monitor closely and provide supportive care</li>
                </ul>
            </div>

            <h3>Contraindications</h3>
            <div class="info-card" style="border-left-color: var(--nhs-red);">
                <h4 style="color: var(--nhs-red);">Absolute Contraindications</h4>
                <ul style="padding-left: 1.5rem;">
                    <li>Known hypersensitivity to methylene blue</li>
                    <li>Glucose-6-phosphate dehydrogenase (G6PD) deficiency - risk of severe haemolysis</li>
                    <li>Recent use of serotonergic antidepressants (relative - see above)</li>
                </ul>
            </div>

            <h3>Special Populations</h3>
            
            <div class="info-grid">
                <div class="info-card">
                    <h4>Renal Impairment</h4>
                    <ul style="padding-left: 1.5rem; margin-top: 0.5rem;">
                        <li>Reduce initial bolus to &lt;1mg/kg</li>
                        <li>Use lower end of infusion range (0.25 mg/kg/hr)</li>
                        <li>Monitor closely for adverse effects</li>
                    </ul>
                </div>

                <div class="info-card">
                    <h4>Hepatic Impairment</h4>
                    <ul style="padding-left: 1.5rem; margin-top: 0.5rem;">
                        <li>No experience in severe hepatic impairment</li>
                        <li>Use with extreme caution</li>
                        <li>Consider dose reduction</li>
                    </ul>
                </div>
            </div>

            <h3>Compatibility</h3>
            <div class="key-point">
                <strong>Compatible with:</strong> Glucose 5% only<br>
                <strong>Incompatible with:</strong> Sodium chloride 0.9% and all saline-containing solutions
            </div>

            <h3>Contact & Escalation</h3>
            <div class="info-grid">
                <div class="info-card" style="border-left-color: var(--nhs-red);">
                    <h4>Emergency Contact</h4>
                    <p>Critical Care Pharmacy team or Senior ICU medical team</p>
                    <p><strong>Phone: 27139</strong></p>
                </div>

                <div class="info-card">
                    <h4>Non-Emergency Advice</h4>
                    <p>Critical Care Pharmacy team</p>
                    <p>Matt Govier (ICU Consultant)<br>matthew.govier@uhbw.nhs.uk</p>
                </div>
            </div>
        </div>

        <div id="references" class="tab-content">
            <h2>Evidence Base & References</h2>

            <div class="references">
                <h3>Key Clinical Trials</h3>
                <ol>
                    <li>
                        <strong>Kirov MY, Evgenov OV, Evgenov NV, et al.</strong> Infusion of methylene blue in human septic shock: a pilot, randomized, controlled study. <em>Crit Care Med.</em> 2001;29(10):1860-1867.
                        <div style="margin-top: 0.3rem; color: var(--nhs-grey); font-size: 0.9rem;">
                            Landmark pilot RCT demonstrating methylene blue's efficacy in reducing vasopressor requirements in septic shock.
                        </div>
                    </li>
                    <li>
                        <strong>Ibarra-Estrada M, Kattan E, Aguilera-González P, et al.</strong> Early adjunctive methylene blue in patients with septic shock: a randomized controlled trial. <em>Crit Care.</em> 2023;27:110.
                        <div style="margin-top: 0.3rem; color: var(--nhs-grey); font-size: 0.9rem;">
                            Recent multicentre RCT showing potential benefits of early methylene blue administration in septic shock.
                        </div>
                    </li>
                </ol>

                <h3 style="margin-top: 1.5rem;">Reviews & Guidelines</h3>
                <ol start="3">
                    <li>
                        <strong>Shanmugam G.</strong> Vasoplegic syndrome – the role of methylene blue. <em>Eur J Cardiothorac Surg.</em> 2005;28:705-710.
                        <div style="margin-top: 0.3rem; color: var(--nhs-grey); font-size: 0.9rem;">
                            Comprehensive review of methylene blue's role in post-CPB vasoplegia.
                        </div>
                    </li>
                    <li>
                        <strong>Fischer GW, Levin MA.</strong> Vasoplegia during cardiac surgery: Current concepts and management. <em>Semin Thorac Cardiovasc Surg.</em> 2010;22(2):140-144.
                        <div style="margin-top: 0.3rem; color: var(--nhs-grey); font-size: 0.9rem;">
                            Overview of vasoplegic syndrome pathophysiology and treatment strategies.
                        </div>
                    </li>
                </ol>

                <h3 style="margin-top: 1.5rem;">Safety & Regulatory</h3>
                <ol start="5">
                    <li>
                        <strong>MHRA Drug Safety Update, April 2009.</strong> Methylthioninium chloride (methylene blue): Update on CNS toxicity with serotonergic drugs.
                        <div style="margin-top: 0.3rem; color: var(--nhs-grey); font-size: 0.9rem;">
                            Official regulatory guidance on serotonergic drug interactions.
                        </div>
                    </li>
                    <li>
                        <strong>Vutskits L, Briner A, Klauser P, et al.</strong> Adverse effects of methylene blue on the central nervous system. <em>Anesthesiology.</em> 2008;108:684-692.
                        <div style="margin-top: 0.3rem; color: var(--nhs-grey); font-size: 0.9rem;">
                            Detailed analysis of CNS adverse effects and mechanisms.
                        </div>
                    </li>
                </ol>

                <h3 style="margin-top: 1.5rem;">Supporting Guidelines</h3>
                <ol start="7">
                    <li>Royal Brompton and Harefield Hospitals Clinical Guidelines - Methylene Blue (Methylthioninium Chloride)</li>
                    <li>
                        <strong>Medusa Injectable Medicines Guide.</strong> Methylthioninium chloride. Available via <a href="http://medusa.wales.nhs.uk" target="_blank" style="color: var(--nhs-blue);">http://medusa.wales.nhs.uk</a> (via Trust intranet). Accessed 10/05/23.
                    </li>
                    <li>
                        <strong>TOXBASE.</strong> Methylene Blue (antidote). Available via <a href="https://www.toxbase.org" target="_blank" style="color: var(--nhs-blue);">https://www.toxbase.org</a>. Accessed 10/05/23.
                    </li>
                </ol>
            </div>

            <h3>Related UHBW Guidelines</h3>
            <div class="info-card">
                <ul style="padding-left: 1.5rem;">
                    <li>Noradrenaline in Critical Care (pending)</li>
                    <li>Vasopressin - ICU SharePoint and DMS</li>
                    <li>Management of Cardiogenic and Mixed Shock in Critical Care - ICU SharePoint</li>
                </ul>
            </div>

            <div class="alert-box" style="margin-top: 1.5rem;">
                <strong>Audit Requirements</strong><br>
                Datix review of all methylene blue administrations. Critical Care Executive approval pending.
            </div>
        </div>
    </div>

    <script>
        function showTab(tabName) {
            const tabContents = document.querySelectorAll('.tab-content');
            tabContents.forEach(content => content.classList.remove('active'));
            
            const tabs = document.querySelectorAll('.tab');
            tabs.forEach(tab => tab.classList.remove('active'));
            
            document.getElementById(tabName).classList.add('active');
            
            event.target.classList.add('active');
        }

        function calculateDose() {
            const leanWeight = parseFloat(document.getElementById('leanWeight').value);
            const renalFunction = document.getElementById('renalFunction').value;
            const bolusDose = parseFloat(document.getElementById('bolusDose').value);
            const preparation = parseFloat(document.getElementById('preparation').value);

            if (!leanWeight || leanWeight < 30 || leanWeight > 150) {
                alert('Please enter a valid lean body weight (30-150 kg)');
                return;
            }

            let adjustedBolusDose = bolusDose;
            if (renalFunction === 'impaired' && bolusDose > 1) {
                adjustedBolusDose = 0.75;
            }

            const bolusTotal = leanWeight * adjustedBolusDose;
            const bolusVolume = bolusTotal / preparation;

            const repeatBolusTotal = bolusTotal;
            const repeatBolusVolume = bolusVolume;

            const infusionRateMin = leanWeight * 0.25;
            const infusionRateMax = leanWeight * 2.0;
            const infusionRateMinMl = infusionRateMin / 2;
            const infusionRateMaxMl = infusionRateMax / 2;

            let recommendedRate = renalFunction === 'impaired' ? 
                `${infusionRateMin.toFixed(1)} mg/hr (${infusionRateMinMl.toFixed(1)} ml/hr)` :
                `${infusionRateMin.toFixed(1)} - ${infusionRateMax.toFixed(1)} mg/hr (${infusionRateMinMl.toFixed(1)} - ${infusionRateMaxMl.toFixed(1)} ml/hr)`;

            document.getElementById('bolusTotal').textContent = `${bolusTotal.toFixed(1)} mg`;
            document.getElementById('bolusPrep').innerHTML = `Draw up <strong>${bolusVolume.toFixed(1)} ml</strong> of ${preparation}mg/ml preparation`;

            document.getElementById('repeatBolus').textContent = `${repeatBolusTotal.toFixed(1)} mg every 2-3 hours`;
            document.getElementById('repeatPrep').innerHTML = `Draw up <strong>${repeatBolusVolume.toFixed(1)} ml</strong> of ${preparation}mg/ml preparation each time`;

            document.getElementById('infusionRate').textContent = recommendedRate;
            
            let infusionNote = renalFunction === 'impaired' ? 
                `<div style="color: var(--nhs-orange); margin-top: 0.5rem; font-weight: 600;">⚠️ Reduced rate recommended due to renal impairment</div>` : '';
            
            document.getElementById('infusionDetails').innerHTML = 
                `Standard preparation: 500mg in 250ml glucose 5% (2mg/ml concentration)` + infusionNote;

            document.getElementById('results').classList.add('show');

            document.getElementById('results').scrollIntoView({ behavior: 'smooth', block: 'nearest' });
        }
    </script>
</body>
</html>
